Financials Ayr Wellness Inc.

Equities

AYR.A

CA05475P1099

Healthcare Facilities & Services

Delayed Canadian Securities Exchange 03:57:42 2024-05-21 pm EDT 5-day change 1st Jan Change
3.61 CAD -2.43% Intraday chart for Ayr Wellness Inc. +4.03% +48.56%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 249.8 885.8 1,019 86.74 141.7 299.2 - -
Enterprise Value (EV) 2 299.5 949.2 1,247 663.9 726.9 706.1 747.7 299.2
P/E ratio -0.98 x -3.78 x -50.1 x -0.33 x -0.49 x -1.7 x -7.07 x -16 x
Yield - - - - - - - -
Capitalization / Revenue 3.32 x 5.71 x 2.85 x 0.19 x 0.31 x 0.61 x 0.54 x 0.53 x
EV / Revenue 3.98 x 6.12 x 3.49 x 1.43 x 1.57 x 1.44 x 1.35 x 0.53 x
EV / EBITDA 14.3 x 16.9 x 12.7 x 7.65 x 6.38 x 5.76 x 5.17 x 2.18 x
EV / FCF -27.6 x 42.9 x -9.76 x -6.87 x -69.1 x 118 x -22 x -
FCF Yield -3.62% 2.33% -10.2% -14.6% -1.45% 0.85% -4.55% -
Price to Book - 4.44 x 0.85 x - 0.23 x 0.77 x - -
Nbr of stocks (in thousands) 26,502 37,297 67,326 71,718 77,286 110,027 - -
Reference price 3 12.25 30.25 19.14 1.640 2.430 3.700 3.700 3.700
Announcement Date 2/26/20 3/10/21 3/17/22 3/9/23 3/13/24 - - -
1CAD in Million2USD in Million3CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 75.2 155.1 357.6 465.6 463.6 489.6 553.8 561.2
EBITDA 1 20.9 56.19 97.97 86.82 114 122.6 144.5 137.4
EBIT 1 -23.46 16.12 -56.01 -243 -37.21 16.8 22.25 59.6
Operating Margin -31.19% 10.39% -15.66% -52.19% -8.03% 3.43% 4.02% 10.62%
Earnings before Tax (EBT) 1 -159.3 -152 12.31 -210.1 -45.76 -51.24 11.7 30.7
Net income 1 -164.2 -176.3 -16.95 -245.5 -272.4 -146.5 -52.7 22.2
Net margin -218.34% -113.68% -4.74% -52.72% -58.76% -29.93% -9.52% 3.96%
EPS 2 -12.54 -7.994 -0.3822 -4.935 -4.969 -2.176 -0.5235 -0.2315
Free Cash Flow 1 -10.84 22.14 -127.8 -96.66 -10.51 6 -34 -
FCF margin -14.42% 14.28% -35.73% -20.76% -2.27% 1.23% -6.14% -
FCF Conversion (EBITDA) - 39.41% - - - 4.89% - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/26/20 3/10/21 3/17/22 3/9/23 3/13/24 - - -
1USD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 111.8 111.2 110.1 119.6 124.6 117.7 116.7 114.4 114.8 118 119.7 124.2 128.3 132.9 134
EBITDA 1 26.14 19.5 19.64 21.67 26.01 26.34 29.45 28.43 29.76 29.09 29.57 31.19 32.21 35.7 36
EBIT 1 -13.86 -21.13 -24.8 -20.68 -176.2 -21.68 -4.539 -1.451 -9.544 -1.963 3.5 4.5 5.4 - -
Operating Margin -12.4% -18.99% -22.52% -17.29% -141.41% -18.43% -3.89% -1.27% -8.31% -1.66% 2.92% 3.62% 4.21% - -
Earnings before Tax (EBT) 1 33.41 2.114 -30.56 -26.84 -154.8 -1.205 -18.32 -5.727 -20.51 -96.85 -7.033 -5.667 -5.1 - -
Net income 1 23.79 -7.576 -38.36 -36.12 -166.4 -194.6 -29.93 -19.25 -28.28 -106.1 -30.9 -31.1 -31.1 - -
Net margin 21.28% -6.81% -34.83% -30.19% -133.53% -165.39% -25.64% -16.82% -24.62% -89.86% -25.81% -25.05% -24.24% - -
EPS 2 0.4460 -0.1412 -0.7235 -0.6997 -3.309 -3.752 -0.5540 -0.3415 -0.4996 -1.469 -0.3670 -0.3540 -0.3540 - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/17/22 5/26/22 8/18/22 11/10/22 3/9/23 5/16/23 8/17/23 11/16/23 3/13/24 5/15/24 - - - - -
1USD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 49.7 63.4 228 577 585 407 448 -
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.379 x 1.128 x 2.328 x 6.648 x 5.135 x 3.318 x 3.103 x -
Free Cash Flow 1 -10.8 22.1 -128 -96.7 -10.5 6 -34 -
ROE (net income / shareholders' equity) - -110% -2.6% - -38.8% -15.6% - -
ROA (Net income/ Total Assets) - - - - -16.9% -8.8% - -
Assets 1 - - - - 1,614 1,665 - -
Book Value Per Share 2 - 6.820 22.50 - 10.40 4.820 - -
Cash Flow per Share 2 0.3000 1.650 -0.6100 -0.6700 0.4900 -0.4000 - -
Capex 1 14.4 14.4 100 62.5 27.7 31 24 -
Capex / Sales 19.17% 9.26% 27.96% 13.42% 5.97% 6.33% 4.33% -
Announcement Date 2/26/20 3/10/21 3/17/22 3/9/23 3/13/24 - - -
1USD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.7 CAD
Average target price
6.06 CAD
Spread / Average Target
+63.78%
Consensus
  1. Stock Market
  2. Equities
  3. AYR.A Stock
  4. Financials Ayr Wellness Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW